BIOLARGO, INC. [FORM OF] WARRANT TO PURCHASE COMMON STOCK WITH CALLABLE PROVISIONBiolargo, Inc. • March 31st, 2015 • Chemicals & allied products • California
Company FiledMarch 31st, 2015 Industry JurisdictionTHIS CERTIFIES THAT, for value received, XXXX (the “Holder”), is entitled to subscribe for and purchase from BIOLARGO, INC., a corporation organized under the laws of the state of Delaware (the “Company”), subject to the provisions hereof, commencing at the time periods prescribed herein and ending at 5:00 p.m. California time on December 31, 2016, XXXXX shares (the “Shares”) of common stock, par value, $0.00067, of the Company (the “Common Stock”). The exercise price for each Share subject to this Warrant (the “Warrant Price”) is equal to $0.30. The number of Shares and the Warrant Price are subject to adjustment from time to time as provided in Section 5 of this Warrant.
BIOLARGO, INC. SERIES “A” WARRANT TO PURCHASE COMMON STOCK WITH CALL PROVISIONBiolargo, Inc. • March 31st, 2015 • Chemicals & allied products • Delaware
Company FiledMarch 31st, 2015 Industry JurisdictionTHIS CERTIFIES THAT, for value received, ___________________________ (the “Holder”), is entitled upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date issued set forth above (the “Exercise Date”) and on or prior to the close of business on June 1, 2020 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioLargo, Inc., a Delaware corporation (the “Company”), up to ________ shares (the “Warrant Shares”) of common stock, par value, $0.00067, of the Company (the “Common Stock”). The exercise price per share of the Common Stock under this Warrant shall be $_____ subject to adjustment hereunder (the “Exercise Price”).
STOCK OPTION AGREEMENTStock Option Agreement • March 31st, 2015 • Biolargo, Inc. • Chemicals & allied products • Delaware
Contract Type FiledMarch 31st, 2015 Company Industry JurisdictionThis Non-Qualified Stock Option Agreement (this “Agreement”) is made and entered into as of _________ (the “Grant Date”) by and between BioLargo, Inc., a Delaware corporation (the “Company”), whose address is 3500 W. Garry Ave, Santa Ana, California 92704, and _________________, an individual (“Optionee”). Capitalized terms used herein without definition shall have the meanings given to them in Appendix “A” attached hereto and incorporated herein by this reference).